Hutch News

Hutch News

Stories tagged 'Eric Holland'

Dr. Kevin Cheung receives prestigious ‘Era of Hope’ Scholar Award

$4.1 million, four-year award to advance understanding of breast cancer metastasis

Feb. 22, 2018 | By Diane Mapes / Fred Hutch News Service

Fred Hutch’s Dr. Kevin Cheung, a metastatic breast cancer researcher, has received a $4.1M Department of Defense Breast Cancer Research Program “Era of Hope” Scholar Award.

View story >

Science to watch in 2018: From immunotherapy to gene therapy, big data to new tech

Fred Hutch experts lend their predictions for the coming year’s advances

Jan. 12, 2018 | By Rachel Tompa / Fred Hutch News Service

We asked Fred Hutch researchers for their predictions on scientific advances to watch in the coming year. Look for their tips on what's next in cancer immunotherapy, precision oncology, gene editing, infectious disease research, cancer prevention and more.

View story >

6 things to know about glioblastoma

Following Sen. John McCain’s diagnosis, Fred Hutch experts offer ‘the long view’ on brain cancer research

July 21, 2017 | By Mary Engel / Fred Hutch News Service

Our experts at Fred Hutchinson Cancer Research Center offer the long view on glioblastoma diagnosis, treatment and research in light of Sen. John McCain's recent diagnosis.

View story >

Good News at Fred Hutch

Celebrating faculty and staff achievements

May 25, 2017

A team of Fred Hutch researchers led by principal investigator Dr. Eric Holland has received $400,000 for a two-year pilot study to test several novel immunotherapy approaches for glioma, an aggressive brain cancer. The study was made possible by the generous support of the Bezos family, which since 2009 has donated and leveraged more than $40 million to Fred Hutch for immunotherapy research.

View story >

How mutations in a single gene alter the course of a deadly brain cancer

New laboratory study of glioma links more aggressive immune response to poorer prognosis

May 23, 2017 | By Sabrina Richards / Fred Hutch News Service

A new study in the aggressive brain cancer known as glioma found that higher levels of immune cells correlated with poorer survival.

View story >

'Every basic scientist's dream'

How Dr. Barry Stoddard's lab work helped create an experimental drug for glioblastoma — the same disease that killed his mother

July 27, 2016 | By Rachel Tompa / Fred Hutch News Service

Dr. Barry Stoddard's research to modify a protein from yeast is now helping to fuel a promising therapy for glioblastoma — the disease that killed his mother.

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.